Ra Pharmaceuticals to Present at Upcoming Investor Conferences
CAMBRIDGE, Mass.--(BUSINESS WIRE)--May 14, 2019--
Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that senior management will present at the following upcoming investor conferences:
- The UBS Global Healthcare Conference 2019 on Tuesday, May 21, 2019 at 9:00 a.m. E.T. The conference will be held at the Grand Hyatt New York in New York, NY.
- The 2019 RBC Capital Markets Global Healthcare Conference on Wednesday, May 22, 2019 at 11:30 a.m. E.T. The conference will be held at the InterContinental New York Barclay in New York, NY.
The presentations will be webcast live and can be accessed by visiting the investor relations section of the Company’s website, www.rapharma.com. A replay of each presentation will be available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical-stage biopharmaceutical company focused on leading the field of complement biology to bring innovative and accessible therapies to patients with rare diseases. The Company discovers and develops peptides and small molecules to target key components of the complement cascade. For more information, please visit: www.rapharma.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20190514005074/en/
Natalie Wildenradt, 617-674-9874
David Rosen, 212-600-1902
KEYWORD: UNITED STATES NORTH AMERICA MASSACHUSETTS NEW YORK
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY CLINICAL TRIALS INFECTIOUS DISEASES PHARMACEUTICAL RESEARCH OTHER SCIENCE SCIENCE
SOURCE: Ra Pharmaceuticals, Inc.
Copyright Business Wire 2019.
PUB: 05/14/2019 07:00 AM/DISC: 05/14/2019 07:00 AM